U.S. Diversified Financial Stock News

Veradermics stock in focus after recent price move Veradermics (MANE) drew fresh attention after a single day gain of about 3.6%, putting the US$38.48 share price and the company’s dermatology focused pipeline on more investors’ radar. See our latest analysis for Veradermics. The 3.6% one day share price return comes after a relatively muted 1.9% year to date share price return, suggesting interest around Veradermics is picking up only gradually rather than in a sharp momentum shift. If this...

Belite Bio (BLTE) completed enrollment of 60 adolescents in its global Phase 2/3 DRAGON II trial for tinlarebant in Stargardt disease type 1, marking a key clinical milestone that investors often watch closely. See our latest analysis for Belite Bio. The latest clinical milestone comes on top of a strong run in the shares, with Belite Bio’s 30 day share price return of 18.63% and 90 day share price return of 77.63%. Its 1 year total shareholder return of 249.18% and 3 year total shareholder...

In late 2025 and January 2026, Public Service Enterprise Group gained attention as major banks upgraded their views and New York State approved the extension of its operations services agreement with the Long Island Power Authority through December 31, 2030. Together with comments about potential regulated generation opportunities in New Jersey, these developments highlighted how PSEG’s regulated and contracted businesses may shape its longer-term profile. We’ll now examine how the Long...

If you are wondering whether Zscaler is starting to look attractively priced or still expensive, this article will walk through what the current share price might be implying about its value. The stock last closed at US$167.33, with returns of 16.3% decline over 7 days, 22.8% decline over 30 days, 24.1% decline year to date and 18.6% decline over 1 year, set against a 25.0% gain over 3 years and 26.1% decline over 5 years. Recent news coverage has focused on Zscaler as a key name in cloud...

WesBanco, Inc. recently reported its fourth-quarter and full-year 2025 results, with quarterly net interest income rising to US$222.3 million and net income to US$91.11 million, and also announced that beginning in the first quarter of 2026, dividends on its Series B preferred stock will be US$4.24 million per quarter. An interesting angle for investors is that quarterly earnings per share improved year on year even as full-year earnings per share from continuing operations remained broadly...

In early February 2026, Prestige Consumer Healthcare reported third-quarter fiscal 2026 results showing lower sales and earnings, narrowed full-year revenue guidance to about US$1.10 billion, and detailed continued share repurchases and the recent Pillar5 acquisition amid supply constraints in its Clear Eyes brand. The company highlighted strong free cash flow, reduced leverage, and the flexibility to fund brand investment, selective M&A, and sizeable buybacks at the same time. With recent...

Dianthus Therapeutics, Inc. recently filed a universal shelf registration of up to US$600 million, covering common and preferred stock, debt securities, warrants and units, while also participating in the Guggenheim Emerging Outlook: Biotech Summit 2026 through a CEO fireside chat and investor meetings. This broad financing framework gives the clinical-stage biotech considerable flexibility in how and when it may access capital across different security types. Next, we will examine how the...

Earlier this week, ZoomInfo Technologies (NASDAQ: GTM) reported earnings after previously outperforming revenue expectations and guiding earnings per share ahead of analyst forecasts, while the board granted CEO Henry Schuck a one-time, performance-based option award on 9.7 million shares tied to ambitious targets. This unusually large, performance-linked grant has drawn attention to potential changes in ZoomInfo’s business direction, including sharper execution priorities or the possibility...

Neogen Corporation recently initiated a voluntary recall of all in-date lots of its Vet HYCOAT Hyaluronate Sodium Sterile Solution for animals, after microbial contamination was detected in certain 10 mL/50 mg vials and adverse events were reported in horses when used off-label as intraarticular injections. Although no adverse events have been reported when HYCOAT is used as labeled for topical wound management, the company has extended the recall to additional lot sizes and is working with...

Nurix Therapeutics (NRIX) is in focus after reporting full year 2025 earnings that paired revenue of US$83.98 million with a wider net loss of US$264.46 million, alongside a new US$98.8 million shelf registration. See our latest analysis for Nurix Therapeutics. The latest earnings release and shelf registration have arrived after a volatile stretch, with a 31.03% 90 day share price return contrasting with a 12.69% 30 day decline and a 6.44% 1 year total shareholder return fall. This suggests...

Alvotech recently reported positive top-line results from a pharmacokinetic study for AVT80, its subcutaneous biosimilar candidate to Entyvio, and also finalized new global patent settlements and commercial entry timelines for its aflibercept biosimilar AVT06. In parallel, Alvotech entered expanded supply and commercialization agreements with Sandoz across Canada, Australia and New Zealand, signalling a broader role as a development and manufacturing partner for multiple biosimilars. We’ll...

What Yelp’s Recent Share Performance Tells Investors Yelp (YELP) is drawing attention after a period of weak share performance, with the stock showing negative returns over the past week, month, past 3 months, year, and on a 3 and 5 year basis. See our latest analysis for Yelp. At the latest share price of $24.42, Yelp’s 7 day share price return of a 10.88% decline and year to date share price return of a 19.14% decline sit alongside a 1 year total shareholder return of a 38.43% loss. This...

Leadership transition and what it may mean for investors Louisiana-Pacific (LPX) has drawn fresh attention after announcing a leadership reshuffle, with F. Nicholas Grasberger III set to become independent Chairperson and CEO-elect Jason P. Ringblom joining the Board as director. This shift in Board roles, alongside the retirement of current Chairperson and CEO W. Bradley Southern, raises questions about how governance, capital allocation and long term priorities could evolve for existing and...

Heightened optimism around upcoming earnings has pulled US Foods Holding (USFD) into focus as investors weigh expectations for higher revenue, a possible earnings beat, and management’s margin and network improvement efforts. See our latest analysis for US Foods Holding. Those expectations are coming on the back of strong momentum, with the share price at $90.33 and recent share price returns of 8.02% over 7 days, 19.50% over 30 days, and 24.94% over 90 days. The 1 year total shareholder...

Mister Car Wash has recently reported that weak same-store sales over the past two years and elevated net debt levels are pressuring its operations and funding flexibility. While returns on capital are improving as management focuses on higher-quality investments, the combination of sluggish traffic and high leverage raises questions about how the business will fund future growth without diluting existing shareholders. Next, we’ll look at how concerns over Mister Car Wash’s high leverage...

What Pulse Biosciences’ Recent Move Might Be Telling You Pulse Biosciences (PLSE) has attracted fresh attention after a sharp recent move in its share price, with short term returns outpacing its past year performance and prompting investors to reassess the risk and reward trade off. See our latest analysis for Pulse Biosciences. The 51.6% 1 day share price return, on top of a 35.4% 90 day share price return and a 55.0% year to date share price return, contrasts with a 7.2% decline in 1...

Piper Sandler Companies recently reported strong fourth-quarter and full-year 2025 results, with Q4 revenue of US$666.99 million and net income of US$113.97 million, and declared both a US$5.00 per share special dividend and a US$0.70 quarterly dividend payable in March 2026. The company paired these results with a four-for-one stock split and the ongoing build-out of its investment banking platform, including the acquisition of G Squared and senior hires in energy and power. Against this...

In recent commentary, Vita Coco Company highlighted its evolution into a profitable global functional hydration brand built on an asset-light supply chain, supported by strong guidance for 2025 and growing international reach. An interesting angle for investors is how Vita Coco’s underdog roots, partnership with Keurig Dr Pepper, and disciplined expansion have created a scalable platform for new products and markets. With this backdrop, we’ll examine how Vita Coco’s asset-light supply...

Principal Financial Group is approaching an upcoming earnings report with analysts expecting quarterly earnings per share of US$2.23 and revenues of US$4.11 billion, both higher than the same period a year earlier. Despite JPMorgan downgrading the stock from Overweight to Neutral in the past, the bank highlighted Principal’s stronger business mix, lower tail risk, higher return on equity, and better free cash flow versus many life insurance peers, with potential upside from healthier asset...

StepStone Group (STEP) is back in focus after quarterly results came in ahead of market expectations, supported by strong fee related earnings, record Private Wealth subscriptions, and growing partnerships and product expansion. See our latest analysis for StepStone Group. The latest earnings surprise appears to have checked a recent pullback, with the 1 day share price return of 5.5% partly offsetting a 30 day share price return decline of 13.4%, while a 3 year total shareholder return of...

Boot Barn Holdings, Inc. reported past third-quarter fiscal 2026 results with sales of US$705.64 million and net income of US$85.81 million, and updated full-year guidance that includes anticipated total sales of about US$2.24–2.25 billion and net income of roughly US$222.8–225.8 million. Alongside planning to open 70 new stores and completing a US$37.44 million share repurchase program, management is emphasizing same-store sales growth and margin improvement across both retail and...

Glacier Bancorp at a glance Glacier Bancorp (GBCI) has recently drawn investor attention after a positive daily move, with the share price closing at $53.19. This price action has prompted a closer look at its recent return profile and fundamentals. See our latest analysis for Glacier Bancorp. Beyond today’s move, Glacier Bancorp’s 30-day share price return of 12.71% and 90-day share price return of 25.01%, alongside a 1-year total shareholder return of 8.95%, suggest momentum has been...

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has drawn attention after recent share price moves, with the stock closing at $52.78 and showing double digit total returns over the past year and the past 3 months. See our latest analysis for Zurn Elkay Water Solutions. The recent 3.3% 1 day share price return and 14.7% 30 day share price return suggest momentum has picked up again, while the 39.5% 1 year total shareholder return and 134.0% 3 year total shareholder return point to...

Warren Buffett’s exit as CEO at the end of 2025 has pushed Berkshire Hathaway (BRK.A) into a new chapter, with investors weighing new leadership decisions and considering the role of the company’s large cash reserves. See our latest analysis for Berkshire Hathaway. The share price has climbed over the past week, with a 7 day share price return of 5.55% and a year to date share price return of 2.48%. The 5 year total shareholder return of 108.92% points to strong long term compounding despite...